← SynDRA
DROXIDOPA
SynDRA canonical compound SYN0030031 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | ADRB3 |
|---|
| Mechanism of action | Norepinephrine precursor |
|---|
| Indication | hypertension | Parkinson's Disease |
|---|
| Disease area | cardiology | neurology/psychiatry |
|---|
All known targets
- ADRA1A
- ADRA1B
- ADRA1D
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- ADRB3
- ADRA2A
- CHRM1
- PAH
- TADA2A
Mechanisms of action (all sources)
- Norepinephrine precursor
- ADRA1A AGONIST
- Adrenergic receptor agonist
- ADRA2A AGONIST
- ADRB1 AGONIST
- ADRB2 AGONIST
- ADRA2C AGONIST
- ADRA1D AGONIST
- ADRA1B AGONIST
- ADRA2B AGONIST
- ADRB3 AGONIST
- TADA2A AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- NR1I2
- ACHE
- KDR
- SLC6A4
- SLC6A3
- SLC6A2
- PTGS1
- PGR
- PDE4A
- PDE3A
- OPRM1
- MAOA
- KCNH2
- ADORA3
- HTR2B
- HTR1A
- HRH3
- HDAC6
- F2
- ESR1
- DRD3
- DRD1
- CHRM2
- AR
- TBXA2R
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Catecholamine
- Adrenergic Agents
- Adrenergic Agonists
- Adrenergic alpha-Agonists
- Cardiovascular Agents
- Neurotransmitter Agents
- Peripheral Nervous System Agents
- Sympathomimetics
- Vasoconstrictor Agents
- Anti-Dyskinesia Agents
- Antiparkinson Agents
- Central Nervous System Agents
ATC classes
- C01C · CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES
Cross-references
Synonyms
- NORTHERA
- Northera
- northera
- L-DOPS
- threo-Dopaserine
- L-threo-3,4-Dihydroxyphenylserine
- L-threo-dops
- DOPS
- DL-threo-DOPS
- L-Threodops
- DL-threo-3,4-Dihydroxyphenylserine
- DL-threo-Droxidopa
- DL-threo-Dihydroxyphenylserine
- UNII-J7A92W69L7
- SM 5688
- CHEBI:31524
- Droxidopa (L-DOPS)
- threo-beta,3-Dihydroxy-DL-tyrosine
- EINECS 223-480-5
- beta,3-Dihydroxy-DL-tyrosine threo-
- BRN 2852792
- L-threo-dihydroxyphenylserine
- L-Tyrosine, beta,3-dihydroxy-, (betaR)-
- L-threo DOPS
- THREO-3,4-DIHYDROXYPHENYLSERINE, L-
- J7A92W69L7
- L-dihydroxyphenylserine
- droxidopum
- SM-5688
- L-Tyrosine, beta,3-dihydroxy-, threo-
- threo-DOPS
- 3,4-threo-DOPS
- 3,4-Dihydroxyphenylserine
- erythro 3,4 Dihydroxyphenylserine
- RefChem:56670
- C01CA27
- DTXCID801475428
Reported adverse events
- Cerebrovascular accident
- Chest pain
- Dizziness
- Fatigue
- Headache
- Hyperpyrexia
- Hypertension
- Nausea
- Pancreatitis
Look up DROXIDOPA in the interactive SynDRA portal →